<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.11.81 (http://www.squarespace.com/) on Mon, 13 Feb 2012 11:15:30 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>Brain Imaging</title><link>http://brainscienceblogs.com/brain-imaging/</link><description></description><lastBuildDate>Tue, 25 Mar 2008 22:21:13 +0000</lastBuildDate><copyright></copyright><language>en-US</language><generator>Squarespace Site Server v5.11.81 (http://www.squarespace.com/)</generator><item><title>Brain Imaging</title><category>Brain Imaging</category><dc:creator>Contacts</dc:creator><pubDate>Tue, 25 Mar 2008 21:40:47 +0000</pubDate><link>http://brainscienceblogs.com/brain-imaging/2008/3/25/brain-imaging.html</link><guid isPermaLink="false">140403:2122223:1714322</guid><description><![CDATA[<p><a target="_blank" href="http://www.medworksmedia.com/psychopharmbulletin/index.php">The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication<br />By Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD</a></p><p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22" target="_blank">Fear, Anxiety, and the Neuroimaging of PTSD<br />By Eileen P. Ahearn, MD, PhD, Timothy Juergens, MD, Tracey Smith, PhD, Dean Krahn, MD, MS, and Ned Kalin, MD <br /></a></p><a target="_blank" href="http://www.medworksmedia.com/psychopharmbulletin/index.php"></a>
]]></description><wfw:commentRss>http://brainscienceblogs.com/brain-imaging/rss-comments-entry-1714322.xml</wfw:commentRss></item></channel></rss>
